In support of this idea, we have shown that in CML, the BCR-ABL oncogene is expressed in LSK cells and causes an increase in this cell population [9], [13], and in this study we show that the transition blockade occurs in CML. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.